Vivek Garipalli - Aug 9, 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Director, 10%+ Owner
Signature: /s/Peter J. Rivas as attorney-in-fact for Vivek Garipalli
Stock symbol: CLOV
Transactions as of: Aug 9, 2024
Transactions value $: $999,596
Form type: 4
Date filed: 8/13/2024, 04:06 PM
Previous filing: Jun 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Purchase	$1M	+532K	+60.59%	$1.88	1.41M	Aug 9, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.84 to $1.91, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.84 to $1.91, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4.